💨 Abstract
The US Food and Drug Administration (FDA) has approved the nasal influenza vaccine FluMist by AstraZeneca for self-administration, making it the first such vaccine in the US. It is administered via a spray in the nose and can be taken by individuals aged 2 to 49. The vaccine contains a weakened form of live influenza virus strains and is sprayed in the nose, and a prescription is still required to receive it.
Courtesy: theprint.in
Suggested
Indians likely part of captured crew of Venezuela-linked oil tanker seized by US in Atlantic
ICE fatal shooting of woman leaves Minneapolis on edge
Shelling rocks Syria's Aleppo as clashes intensify between government, Kurdish fighters
Spice routes conference lays road map to strengthen inter-cultural relations
UAE-backed leader’s flight from Yemen pushes Saudi-led anti-Houthi coalition to the brink
Israel bars some aid workers from Gaza as groups face suspension
Explainer-What's happening in Yemen, and why are Saudi Arabia and the UAE involved?
Russian strikes plunge Ukraine's industrial southeast into blackouts
Lebanon army says it takes control of south; Israel says Hezbollah still must disarm
US exit of key UN climate treaty criticized as self-sabotage